The short version
Maximus made its name in direct-to-consumer hormone protocols, especially enclomiphene-based pathways for men who'd rather stimulate endogenous testosterone than replace it outright. The brand is testosterone-shaped: the marketing, the product names, the protocol library all point that direction.
Boswell is a peptide-therapy platform. The unit of value is the peptide protocol — prescribed by a U.S.-licensed physician and compounded by a 503A pharmacy. Members typically arrive having already settled on a compound: sermorelin, CJC-1295 + Ipamorelin, BPC-157, NAD+.
| Topic | Maximus | Boswell |
|---|---|---|
| Primary product | Hormone protocols led by enclomiphene and TRT options | Peptide therapy via licensed providers + 503A compounding |
| Audience | Primarily men | Men and women |
| Starting point | Intake + lab panel, then a hormone protocol | Goals review, provider intake, then a prescribed protocol |
| Peptide menu | Limited; hormone-focused offering | Full peptide menu (BPC-157, TB-500, CJC-1295 + Ipa, NAD+, PT-141, GHK-Cu, MOTS-C, AOD-9604, Sermorelin, Glutathione) |
| Pricing model | Subscription bundling labs + medication | Per-protocol pricing, prescription-required |
| Best fit | You want a hormone-stimulating protocol as a man | You want a specific peptide protocol with provider oversight |
Different jobs to be done
Maximus is structured around can I move my testosterone in the right direction without committing to lifelong replacement? Enclomiphene is the headline answer: a SERM that nudges the HPTA, with the product wrapped around the labs and the follow-up. It's a focused, well-marketed take on a hormone problem.
Boswell is structured around can I get this specific peptide protocol prescribed by a real doctor? The questions are different — sleep, recovery, sexual health, longevity, skin, body composition — and the answers are different compounds. Both platforms are prescription pathways, but they're answering different patient questions.
Enclomiphene is a hormone protocol. BPC-157 is a peptide protocol. Different platforms, on purpose.
When Maximus makes sense
Maximus earns its place when you've decided that hormone optimization — particularly something like enclomiphene — is the right move for you, and you want a brand that's been optimized for exactly that customer. The protocol library is narrower than a comprehensive hormone clinic's, but the focus also means the experience is tight.
It's also a reasonable choice if your goals are squarely in the testosterone-optimization lane and you don't anticipate needing a wide menu of non-hormone compounds. The trade-off is that peptides aren't the headline; if you want one, you may end up assembling care across two providers.
When Boswell makes sense
Boswell earns its place when the question is about a peptide. You want BPC-157 for tissue repair after a sports injury. You want a growth-hormone-releasing peptide stack for sleep and recovery. You want PT-141 for sexual health, NAD+ for cellular energy, or GHK-Cu for skin and tissue repair.
The value is access to the specific compound under a U.S.-licensed prescriber, compounded fresh by a 503A pharmacy, with refill oversight and the labeling and accountability that gray-market vendors don't provide. The peptide menu is wider than what a hormone-focused brand offers. Pricing is per-protocol, so you're paying for the medication, not for a hormone-product wrapper.
Questions worth asking before either
- Is the goal a hormone-optimization outcome or a peptide-mediated outcome?
- If I'm interested in enclomiphene specifically, is that the dominant question I'm trying to answer?
- Is the prescriber a U.S.-licensed physician, and is the pharmacy a 503A compounding pharmacy?
- What does refill oversight look like — who follows up, and when?
- Am I likely to want non-hormone compounds (peptides) over the next 12 months?
Sources